topic

Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases
Giuseppe Minniti, Gaetano Lanzetta, Luca Capone, Martina Giraffa, Ivana Russo, Francesco Cicone, Alessandro Bozzao, Filippo Alongi, Luca Nicosia, Gioia Fineschi, Luca Marchetti, Tommaso Tufo, Federico Bianciardi, Vincenzo Esposito, PierCarlo Gentile, Sergio Paolini

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003730; DOI: 10.1136/jitc-2021-003730
Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al
Paula Martinez Sanz, Dieke J van Rees, Hanke L Matlung, Godelieve A M Tytgat, Katka Franke

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003983; DOI: 10.1136/jitc-2021-003983
In silico modeling of combination systemic therapy for advanced renal cell carcinoma
Ritesh R Kotecha, Dennis J Hsu, Chung-Han Lee, Sujata Patil, Martin H Voss

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e004059; DOI: 10.1136/jitc-2021-004059
Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Martinez Sanz et al
Jaume Mora, Guillermo L Chantada

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003751; DOI: 10.1136/jitc-2021-003751
Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer
Lingli Long, Yue Hu, Tengfei Long, Xiaofang Lu, Ying Tuo, Yubing Li, Min Wang, Zunfu Ke

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003973; DOI: 10.1136/jitc-2021-003973
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival
Manish A Shah, David Cunningham, Jean-Philippe Metges, Eric Van Cutsem, Zev Wainberg, Emon Elboudwarej, Kai-Wen Lin, Scott Turner, Marianna Zavodovskaya, David Inzunza, Jinfeng Liu, Scott D Patterson, Jingzhu Zhou, Jing He, Dung Thai, Pankaj Bhargava, Carrie Baker Brachmann, Daniel V T Cantenacci

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003580; DOI: 10.1136/jitc-2021-003580
Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial
Victor Moreno, Maria-Pilar Barretina-Ginesta, Jesús García-Donas, Gordon C Jayson, Patricia Roxburgh, Raúl Márquez Vázquez, Agnieszka Michael, Antonio Antón-Torres, Richard Brown, David Krige, Brian Champion, Iain McNeish

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003645; DOI: 10.1136/jitc-2021-003645
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities
Ilias Christodoulou, Won Jin Ho, Andrew Marple, Jonas W Ravich, Ada Tam, Ruyan Rahnama, Adam Fearnow, Cambrynne Rietberg, Sean Yanik, Elena E Solomou, Ravi Varadhan, Michael A Koldobskiy, Challice L Bonifant

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003894; DOI: 10.1136/jitc-2021-003894
Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers
Jung Ho Kim, Mi-Kyoung Seo, Ji Ae Lee, Seung-Yeon Yoo, Hyeon Jeong Oh, Hyundeok Kang, Nam-Yun Cho, Jeong Mo Bae, Gyeong Hoon Kang, Sangwoo Kim

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003414; DOI: 10.1136/jitc-2021-003414
Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells
Songbo Zhao, Chunhua Wang, Ping Lu, Yalin Lou, Huimin Liu, Ting Wang, Shanshan Yang, Ziyou Bao, Lin Han, Xiaohong Liang, Chunhong Ma, Lifen Gao

Journal for ImmunoTherapy of Cancer Dec 2021, 9 (12) e003176; DOI: 10.1136/jitc-2021-003176

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages